Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Elizabeth T. Loggers"'
Autor:
Kelly G. Paulson, Vinod Ravi, Brian P. Rubin, Min Park, Elizabeth T. Loggers, Lee D. Cranmer, Michael J. Wagner
Publikováno v:
Cancer Medicine, Vol 12, Iss 14, Pp 15101-15106 (2023)
Abstract Background Malignant hemangioendothelioma is an endothelial cancer with heterogeneous clinical behavior that can range from indolent to aggressive, of which the majority are epithelioid (EHE). Its incidence and demographics have not been pre
Externí odkaz:
https://doaj.org/article/b3ec2e3c2c0f43889a2818e3d3728470
Autor:
Steven Attia, Vanessa Bolejack, Kristen N. Ganjoo, Suzanne George, Mark Agulnik, Daniel Rushing, Elizabeth T. Loggers, Michael B. Livingston, Jennifer Wright, Sant P. Chawla, Scott H. Okuno, Denise K. Reinke, Richard F. Riedel, Lara E. Davis, Christopher W. Ryan, Robert G. Maki
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1532-1539 (2023)
Abstract Background Regorafenib is one of several FDA‐approved cancer therapies targeting multiple tyrosine kinases. However, there are few subtype‐specific data regarding kinase inhibitor activity in sarcomas. We report results of a single arm,
Externí odkaz:
https://doaj.org/article/124378635bd247fb9b2242a52cc12063
Autor:
Christopher W. Chalaka, MD, Heather M. Mahurin, MD, Erica Tarabadkar, MD, Daniel S. Hippe, MS, Elizabeth T. Loggers, MD, PhD, Michi M. Shinohara, MD
Publikováno v:
International Journal of Women's Dermatology, Vol 9, Iss 2, p e085 (2023)
Background:. Patients with cutaneous T-cell lymphoma (CTCL) often experience debilitating symptoms that impair health-related quality of life (HRQoL). Existing evidence for HRQoL differences with respect to gender is conflicting. Objective:. To inves
Externí odkaz:
https://doaj.org/article/0202df776d1c44d584a5393e8354733f
Autor:
Heather M. Mahurin, Erica Tarabadkar, Daniel S. Hippe, Kristina Lachance, Ellen J. Kim, Elizabeth T. Loggers, Michi M. Shinohara
Publikováno v:
Complementary Therapies in Medicine, Vol 61, Iss , Pp 102762- (2021)
Objectives: To characterize patterns of integrative medicine (IM) use and health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma (CTCL). Design: Cross-sectional, online survey, created in conjunction with the Cutaneous Lymp
Externí odkaz:
https://doaj.org/article/9426d1f1e7f94005baeffed889dcd9dd
Autor:
Michael J. Wagner, Robert W. Ricciotti, Jose Mantilla, Elizabeth T. Loggers, Seth M. Pollack, Lee D. Cranmer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-4 (2018)
Abstract Background Chondrosarcoma is one of the most common malignant bone tumors in adults. Conventional chondrosarcoma represents around 85% of all chondrosarcomas and is notoriously difficult to treat with chemotherapy. Case presentation We descr
Externí odkaz:
https://doaj.org/article/d2985005c8ee4377ac381eafa38dbf81
Publikováno v:
Marine Drugs, Vol 13, Iss 2, Pp 974-983 (2015)
Soft tissue sarcomas are a group of rare tumors derived from mesenchymal tissue, accounting for about 1% of adult cancers. There are over 60 different histological subtypes, each with their own unique biological behavior and response to systemic ther
Externí odkaz:
https://doaj.org/article/6ee990e4d7d247a399b7947c690eac93
Autor:
Amy E. Chang, Gary N. Mann, Benjamin Hoch, Elizabeth T. Loggers, Seth M. Pollack, Orpheus Kolokythas, Robin L. Jones
Publikováno v:
Rare Tumors, Vol 5, Iss 3, Pp e51-e51 (2013)
Gastrointestinal stromal tumors are the most common mesenchymal tumors of the gastrointestinal tract. The introduction of a number of small molecule tyrosine kinase inhibitors has revolutionized the management of metastatic disease. Surgery is the ma
Externí odkaz:
https://doaj.org/article/b92ec0ffde284aa893a778715b5b21de
Publikováno v:
Rare Tumors, Vol 4, Iss 4, Pp e55-e55 (2012)
Primary splenic angiosarcoma is a very rare neoplasm with a high propensity for metastatic disease and poor prognosis. There is a paucity of literature concerning this specific sarcoma subtype and the role of systemic therapy is not well defined. A r
Externí odkaz:
https://doaj.org/article/5130863722084e25b753d76839b5c3aa
Publikováno v:
Sarcoma, Vol 2011 (2011)
Immunotherapy has shown promise in a number of tumor types, but its exact role in sarcoma remains to be defined. Advanced bone and soft tissue sarcomas are challenging diseases to treat with an unmet need for effective systemic therapy. Previous repo
Externí odkaz:
https://doaj.org/article/5c4a9d22a57341efaa2ea0c946d2add4
Autor:
Lee D. Cranmer, Yao Lu, Rachel S. Heise, Karla V. Ballman, Elizabeth T. Loggers, Seth M. Pollack, Michael J. Wagner, Denise K. Reinke, Patrick Schöffski, William D. Tap
Publikováno v:
Clinical Cancer Research. 29:1068-1076
Purpose:Continuous intravenous infusion (CIV) of doxorubicin (DOX) versus bolus (BOL) may minimize dose-dependent DOX cardiomyopathy, but it is unclear whether this advantage is evident as employed in typical soft-tissue sarcoma (STS) treatment. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1bca9f14891433cc966c2bfe6d72992
https://doi.org/10.1158/1078-0432.ccr-22-1564
https://doi.org/10.1158/1078-0432.ccr-22-1564